David de Vries is a co-founder and Chief Operating Officer at Tr1X, where the focus is on engineering cures for autoimmune diseases by harnessing innovative tools and treatment modalities. Concurrently, David serves as a co-founder at Arine, dedicated to delivering customized, data-driven clinical services through a cloud-based platform. Previous roles include Director of Commercial Development and Strategy at Proteus Digital Health, Associate at RAND Health, and Associate Researcher at the Salk Institute for Biological Studies. David's academic background includes an A.B. in Neurobiology, Global Health and Health Policy from Harvard University, and a Master of Philosophy in Chemical Engineering and Biotechnology from the University of Cambridge.
This person is not in the org chart
This person is not in any teams
This person is not in any offices